SOPH NASDAQ
SOPHiA GENETICS S.A.
1W: +6.5%
1M: -1.6%
3M: +6.3%
YTD: +8.1%
1Y: +75.3%
3Y: +19.4%
$4.88
-0.17 (-3.37%)
Weekly Expected Move ±8.3%
$4
$4
$5
$5
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$349.7M
52W Range2.59-5.7
Volume99,981
Avg Volume102,864
Beta1.01
Dividend—
Analyst Ratings
Company Info
CEOJurgi Camblong
Employees423
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-07-23
Websitesophiagenetics.com
Rue du Centre 172
Rolle 1025
CH
Rolle 1025
CH
41 21 694 10 60
About SOPHiA GENETICS S.A.
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Muken Ross | S-Sale | 761 | $4.60 | 2026-05-19 |
| Xu Zhenyu | S-Sale | 608 | $4.60 | 2026-05-19 |
| Camblong Jurgi | S-Sale | 4,486 | $4.60 | 2026-05-19 |
| Menu Philippe | S-Sale | 608 | $4.61 | 2026-05-19 |
| Van Well Daan | S-Sale | 684 | $4.60 | 2026-05-19 |